Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review

Myriam Drysdale, Mehmet Berktas, Daniel C. Gibbons, Catherine Rolland, Louis Lavoie, Emily J. Lloyd
doi: https://doi.org/10.1101/2023.12.04.23299370

Article usage

Article usage: December 2023 to June 2025

AbstractFullPdf
Dec 2023271647
Jan 202464013
Feb 20243537
Mar 202424011
Apr 202417510
May 20241211
Jun 20241736
Jul 202424111
Aug 2024623
Sep 20241519
Oct 20245510
Nov 20241626
Dec 20249215
Jan 202518310
Feb 20251133
Mar 20252857
Apr 20252227
May 202529915
Jun 2025291025
Back to top
Posted December 04, 2023.
Download PDF

Supplementary Material

Email
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review
Myriam Drysdale, Mehmet Berktas, Daniel C. Gibbons, Catherine Rolland, Louis Lavoie, Emily J. Lloyd
medRxiv 2023.12.04.23299370; doi: https://doi.org/10.1101/2023.12.04.23299370
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area